News | Patient Positioning Radiation Therapy | July 19, 2019

Global revenues for radiotherapy patient positioning devices to exceed $500 million in 2019

Stronger Distribution Networks to Bolster Radiotherapy Patient Positioning Accessories

July 17, 2019 — A recent study projects global market revenues for radiotherapy patient positioning accessories will exceed revenues of $500 million in 2019. This represents a moderate 4.3 percent annual growth over 2018, with nearly 1/5 of the overall installed base of radiotherapy patient positioning accessories accounted for by couch tops and overlays, followed by immobilization systems.

More than 40 percent of the total adoption of radiotherapy patient positioning accessories is registered by hospitals at a global level, as indicated by the report from Future Market Insights. A higher rate of demand for radiotherapy patient positioning accessories is likely to be recorded by cancer research institutes and radiation therapy/proton therapy centers in the forthcoming years.

Government Support Pivotal in Accelerating Installation of Radiotherapy Patient Positioning Accessories

North America and Europe currently hold a combined revenue share of more than 60 percent in the global radiotherapy patient positioning accessories market. A remarkable increase in the rate of early cancer diagnosis is leading to a hike in the adoption of radiotherapy, more prominently in developed countries such as the U.S., U.K. and Germany among others, according to the FMI report. Moreover, the study opines that the increasing awareness about multiple types of cancers, further backed by favorable government initiatives regarding cancer diagnosis and treatment, will be one of the strongest factors pushing penetration of radiotherapy patient positioning accessories within developed regional markets.

On the other side, governments of several developing economies are also extending support and investments in the cancer diagnosis and treatment space, particularly through screening camps, which is boosting the diagnosis rates of cancer. This according to the report is majorly responsible for promising growth in the installed base of radiotherapy systems and patient positioning accessories. According to analysis, the flourishing medical tourism sector is also registering significant contribution to the thriving demand for radiotherapy patient positioning accessories in emerging economies.

Strategic Efforts in Stronger Distribution Network Gathering Momentum Among Manufacturers

Some of the key players actively competing in the radiotherapy patient positioning accessories market include Bionix Radiation Therapy, CDR Systems, Civco Radiation, Orfit Industries N.V., IZI Medical Products, Klarity Medical Products, Qfix, Elekta AB, and Eckert & Ziegler BEBIG, among others. Several leading manufacturers are focused on the development and approval of new products. For example, Civco Radiotherapy announced U.S. Food and Drug Administration (FDA) clearance and CE mark for their Solstice SRS (stereotactic radiosurgery) Immobilization System, in the second half of 2018.

Strong distribution partnerships tend to result in effective product reach across the value chain and thereby support the business growth. While the growing trend of strategic distribution partnerships between peer companies operating in the radiotherapy patient positioning accessories market is translating into improved product outreach, the analysis suggests that collaborative activities will particularly benefit smaller players in the market. Recently, Poll Medical entered a partnership with Civco for the global distribution of Poll’s CE-marked GrayDuck Stents, a new custom oral stent to provide immobilization and tissue sparing of the tongue during head and neck radiotherapy. 

Access the full FMI report here.

For more information:

Related Content

News | Mammography

September 26, 2023 — Artificial intelligence(AI) and machine learning tools have received a lot of attention recently ...

Time September 26, 2023
Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
News | Ultrasound Imaging

September 8, 2023 — When diagnosing and treating cancer patients, the dynamics of blood flow to and from a suspected ...

Time September 08, 2023
News | ASTRO

September 7, 2023 — American Society for Radiation Oncology (ASTRO) President Jeff Michalski, MD, MBA, FASTRO, will join ...

Time September 07, 2023
News | Radiation Oncology

September 6, 2023 — Nina D’Abreo, MD, has been named as chief of the Division of Hematology and Medical Oncology at NYU ...

Time September 06, 2023
Feature | Radiology Business | By Melinda Taschetta-Millane

As we wind down the summer months, ITN takes a look at the Top 10 most-read pieces of content from ...

Time August 31, 2023
Subscribe Now